Sanofi jumps in­to a piv­otal study for next-gen Pompe drug

Sanofi has added an­oth­er bad­ly-need­ed drug to its late-stage port­fo­lio. The drug, dubbed neoGAA, is be­ing ad­vanced by its big Gen­zyme unit in Boston, which …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.